Amneal [AMRX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison
Amneal
NASDAQ
Loading...
Haleon Plc - ADR
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Amneal wins in 10 metrics, Haleon Plc - ADR wins in 9 metrics, with 0 ties. Amneal appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amneal | Haleon Plc - ADR | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 953.00 | 21.82 | Haleon Plc - ADR |
| Price-to-Book Ratio | -26.76 | 5.54 | Amneal |
| Debt-to-Equity Ratio | -22.94 | 53.41 | Amneal |
| PEG Ratio | 3.81 | 23.38 | Amneal |
| EV/EBITDA | 8.90 | 36.60 | Amneal |
| Profit Margin (TTM) | 0.12% | 13.81% | Haleon Plc - ADR |
| Operating Margin (TTM) | 15.46% | 22.21% | Haleon Plc - ADR |
| EBITDA Margin (TTM) | 15.46% | 22.21% | Haleon Plc - ADR |
| Return on Equity | 106.73% | 9.38% | Amneal |
| Return on Assets (TTM) | 6.85% | 4.61% | Amneal |
| Free Cash Flow (TTM) | $220.11M | $2.68B | Haleon Plc - ADR |
| Dividend Yield | N/A | 1.63% | N/A |
| 1-Year Return | 14.44% | -0.81% | Amneal |
| Price-to-Sales Ratio (TTM) | 1.05 | 4.06 | Amneal |
| Enterprise Value | $5.57B | $129.28B | Haleon Plc - ADR |
| EV/Revenue Ratio | 1.95 | 8.72 | Amneal |
| Gross Profit Margin (TTM) | 39.51% | 55.38% | Haleon Plc - ADR |
| Revenue per Share (TTM) | $9 | $2 | Amneal |
| Earnings per Share (Diluted) | $0.01 | $0.45 | Haleon Plc - ADR |
| Beta (Stock Volatility) | 1.12 | 0.24 | Haleon Plc - ADR |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amneal vs Haleon Plc - ADR Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amneal | 0.63% | 1.48% | 20.48% | 33.38% | 15.54% | 23.58% |
| Haleon Plc - ADR | 0.10% | 1.76% | 1.76% | -11.21% | -3.25% | 4.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amneal | 14.44% | 280.56% | 137.97% | -34.76% | -34.76% | -34.76% |
| Haleon Plc - ADR | -0.81% | 57.62% | 32.52% | 32.52% | 32.52% | 32.52% |
Performance & Financial Health Analysis: Amneal vs Haleon Plc - ADR
| Metric | AMRX | HLN |
|---|---|---|
| Market Information | ||
| Market Cap | $2.99B | $44.69B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,865,350 | 7,977,726 |
| 90 Day Avg. Volume | 1,528,157 | 10,685,552 |
| Last Close | $9.59 | $9.82 |
| 52 Week Range | $6.68 - $9.79 | $8.86 - $11.42 |
| % from 52W High | -2.04% | -14.01% |
| All-Time High | $24.48 (Aug 20, 2018) | $11.42 (Jun 02, 2025) |
| % from All-Time High | -60.83% | -14.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | -0.01% |
| Quarterly Earnings Growth | 2.74% | 0.33% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.14% |
| Operating Margin (TTM) | 0.15% | 0.22% |
| Return on Equity (TTM) | 1.07% | 0.09% |
| Debt to Equity (MRQ) | -22.94 | 53.41 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.36 | $1.77 |
| Cash per Share (MRQ) | $0.24 | $0.08 |
| Operating Cash Flow (TTM) | $351.08M | $3.34B |
| Levered Free Cash Flow (TTM) | $333.75M | $2.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.63% |
| Last 12-Month Dividend | N/A | $0.17 |
Valuation & Enterprise Metrics Analysis: Amneal vs Haleon Plc - ADR
| Metric | AMRX | HLN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 953.00 | 21.82 |
| Forward P/E | 13.42 | 23.38 |
| PEG Ratio | 3.81 | 23.38 |
| Price to Sales (TTM) | 1.05 | 4.06 |
| Price to Book (MRQ) | -26.76 | 5.54 |
| Market Capitalization | ||
| Market Capitalization | $2.99B | $44.69B |
| Enterprise Value | $5.57B | $129.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.95 | 8.72 |
| Enterprise to EBITDA | 8.90 | 36.60 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 0.24 |
| Book Value per Share (MRQ) | $-0.36 | $1.77 |
Financial Statements Comparison: Amneal vs Haleon Plc - ADR
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMRX | HLN |
|---|---|---|
| Revenue/Sales | $695.42M | $3.71B |
| Cost of Goods Sold | $439.53M | $1.66B |
| Gross Profit | $255.89M | $2.06B |
| Research & Development | $41.81M | $104.93M |
| Operating Income (EBIT) | $100.92M | $470.83M |
| EBITDA | $161.60M | $486.97M |
| Pre-Tax Income | $37.49M | $387.43M |
| Income Tax | $12.87M | $88.79M |
| Net Income (Profit) | $24.62M | $298.64M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMRX | HLN |
|---|---|---|
| Cash & Equivalents | $59.19M | $2.97B |
| Total Current Assets | $1.51B | $7.73B |
| Total Current Liabilities | $1.08B | $7.86B |
| Long-Term Debt | $2.24B | $11.65B |
| Total Shareholders Equity | $-59.39M | $21.94B |
| Retained Earnings | $-594.87M | $36.87B |
| Property, Plant & Equipment | $522.75M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMRX | HLN |
|---|---|---|
| Operating Cash Flow | $-11.03M | N/A |
| Capital Expenditures | $-13.60M | N/A |
| Free Cash Flow | $-10.91M | N/A |
| Debt Repayment | $-235.53M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMRX | HLN |
|---|---|---|
| Shares Short | 4.93M | 17.45M |
| Short Ratio | 3.55 | 1.39 |
| Short % of Float | 0.02% | 0.00% |
| Average Daily Volume (10 Day) | 1,865,350 | 7,977,726 |
| Average Daily Volume (90 Day) | 1,528,157 | 10,685,552 |
| Shares Outstanding | 309.88M | 12.27B |
| Float Shares | 168.50M | 8.95B |
| % Held by Insiders | 0.47% | 0.00% |
| % Held by Institutions | 0.46% | 0.13% |
Dividend Analysis & Yield Comparison: Amneal vs Haleon Plc - ADR
| Metric | AMRX | HLN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.17 |
| Last 12-Month Dividend Yield | N/A | 1.63% |
| 3-Year Avg Annual Dividend | N/A | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.91% |
| 3-Year Total Dividends | N/A | $0.34 |
| Ex-Dividend Date | N/A | Apr 25, 2025 |